Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
July 31, 2026 40.73%
April 30, 2026 44.53%
January 31, 2026 17.02%
October 31, 2025 18.20%
July 31, 2025 23.86%
April 30, 2025 36.48%
January 31, 2025 42.75%
October 31, 2024 27.81%
July 31, 2024 20.51%
April 30, 2024 37.75%
January 31, 2024 32.44%
October 31, 2023 34.64%
July 31, 2023 44.05%
April 30, 2023 44.35%
January 31, 2023 24.53%
October 31, 2022 43.48%
Date Value
July 31, 2022 33.28%
April 30, 2022 41.95%
January 31, 2022 21.00%
October 31, 2021 38.62%
July 31, 2021 12.63%
April 30, 2021 54.88%
January 31, 2021 53.55%
October 31, 2020 41.60%
July 31, 2020 -38.51%
April 30, 2020 37.19%
January 31, 2020 -544.4%
October 31, 2019 -28.57%
July 31, 2019 -57.41%
April 30, 2019 -2.69%
January 31, 2019 0.61%
October 31, 2018 -26.72%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 54.97%
Corcept Therapeutics, Inc. 98.41%
Veru, Inc. --
Johnson & Johnson 68.73%
Eli Lilly & Co. 85.78%

Gross Profit Margin (Quarterly) Related Metrics